Dyania Health

Dyania Health develops Synapsis AI, a medically trained artificial intelligence and natural language processing system that reads and interprets electronic medical records to automate chart review. The company states that Synapsis AI can read and interpret an EMR in approximately 0.5 seconds using two GPUs, compared with roughly 30 minutes for a human reader. Applications marketed by the company include Patient Finder for trial pre-screening and enrollment, registries reporting, observational studies, study feasibility assessment, and evidence-guided care pathways.

The platform is deployed inside the customer's environment: software is installed behind the healthcare system firewall, on-premise or in a private cloud, so that patient data does not leave the health system, which the company positions as supporting HIPAA, HITRUST and GDPR compliance requirements. Dyania performs a one-time deployment and ongoing maintenance, with team members accessing sandboxed environments via VPN or the health system's access management solution. An in-house physician team participates in protocol assessment and scoping, deconstruction of trial eligibility criteria into deterministic logic for the reasoning engine, drafting protocols for investigator-initiated retrospective studies, and adjudicating true and false positives and negatives before results are delivered to customers.

The company name derives from the Greek word "διάνοια," referring to intelligence or acumen.

Business model

Dyania Health licenses and deploys its Synapsis AI software within healthcare systems' own computing environments, combining the technology with services delivered by an in-house physician team, including protocol scoping, criteria translation into machine logic, study protocol drafting and results review. Deployment involves a one-time installation performed by Dyania along with ongoing maintenance; hardware requirements, including GPUs, scale with patient population, number of trials, studies or reporting projects, and disease areas.

Traction

The company reports deployment of its AI platform across the Cleveland Clinic health system for clinical trial recruitment, and cites peer-reviewed and conference-presented studies of Synapsis AI, including publications in the Journal of Cardiac Failure and presentations at ASH 2025, ASCO 2025 and ACC.25 covering transthyretin cardiac amyloidosis screening, melanoma data abstraction and polycythemia vera trial screening. Awards include a 2025 Fierce Innovation Award in Artificial Intelligence Solutions, a Fierce Healthcare award for Excellence in Data-Driven DEI Practices, inclusion in the New York Digital Health 100, and acceptance into the 2025 CancerX Accelerator Program.